Form 4 for LFCR LIFECORE BIOMEDICAL, INC. DE
Accepted 2026-05-21 16:28:13 ET · period of report 2026-05-20 · accession 0002022547-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 16:28 | 2026-05-20 | LFCR | Josephs Paul | CEO, Dir | F - Tax | $4.57 | -40.4K | 592.9K | -6% | -$184.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-20 | F | D | 40,413 | $4.57 | 592,915 | D | — | — | (F1) Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of an RSU vesting. |